CYTK
Cytokinetics Inc
68.80$
-1.6%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 94.6% | 161.9% | 56.3% | 675.5% | 283.0% | 320.5% | 173.7% | 227.1% | 254.6% | 4,384.1% | 1,837.2% | 11.5% | |
| 5.4% | -61.9% | 43.7% | -575.5% | -183.0% | -220.5% | -73.7% | -127.1% | -154.6% | -4,284.1% | -1,737.2% | 88.5% | |
| 94.6% | 161.9% | 56.3% | 675.5% | 283.0% | 320.5% | 173.7% | 227.1% | 254.6% | 4,384.1% | 1,837.2% | 461.0% | |
| 36.8% | 68.6% | 26.1% | 272.8% | 99.3% | 147.4% | 94.6% | 137.4% | 188.2% | 2,305.6% | 1,165.5% | 322.9% | |
| 36.8% | 68.6% | 26.1% | 272.8% | 99.3% | 147.4% | 94.6% | 137.4% | 188.2% | 2,305.6% | 1,165.5% | 783.9% | |
| -31.4% | -130.5% | 17.6% | -848.3% | -282.3% | -368.0% | -168.3% | -264.5% | -342.8% | -6,589.7% | -2,902.7% | -695.4% | |
| 0.2% | 0.3% | 2.1% | 127.1% | 68.5% | 101.8% | 69.3% | 41.6% | 54.1% | 765.8% | 468.3% | 118.0% | |
| -31.2% | -130.9% | 15.5% | -955.9% | -337.4% | -452.9% | -228.0% | -305.7% | -411.2% | -6,988.6% | -3,191.1% | -891.6% | |
| -1.0% | -2.1% | -0.7% | 5.1% | 13.3% | 101.8% | 66.0% | 38.4% | 14.4% | 155.7% | – | – | |
| -31.2% | -130.9% | 15.5% | -955.9% | -337.4% | -452.9% | -228.0% | -305.7% | -411.2% | -6,988.6% | -3,191.1% | -891.6% | |
| -30.4% | -128.5% | 18.3% | -814.6% | -265.0% | -346.3% | -155.4% | -250.4% | -348.2% | -6,064.9% | -2,671.2% | -880.6% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.